PCR Testing of Infectious pathogens
Cultures are non-productive.
With Polymerase Chain Reaction (PCR) testing clinicians are able to know exactly which micro-organisms are present in any given infection, especially when multiple viral and multiple bacterial pathogens can be found residing within the same infection. PCR allows us to match the bacterial and fungal DNA/RNA from your sample to the all the known pathogens. Once the pathogenic organisms are identified, medications can be selected and ratios adjusted to specifically address that individual.
We must utilize molecular diagnostics to maximize healing outcomes.
The dramatic advantages we offer over traditional culture-based analysis have been clearly proven through years of PCR studies. Our testing allows for a precise treatment that ultimately expedites healing - 4 to 6 - times faster without recurring events. These specifically developed treatments are often referred to as Personalized Medicine. Most insurance companies cover our services.
Antibiotic Resistance Benefits
These results are proven to be more accurate than cultures:
Better Diagnostics – Molecular Pathology Detection
Rapid Results – 24 hours after sample arrival at lab
Comprehensive Offering - Detects 125+ pathogens
Resistance Gene Identification (30 resistance genes - largest panel on the commercial market)
Sanford Guide Integration, the most trusted source in the treatment of infectious disease - FDA guidance.
Did you know?
Researchers are estimating that about 200 million people are infected by viral community-acquired pneumonia every year. Approximately 100 million of these cases are children, and 100 million are adults. Molecular diagnostic (PCR) tests have shed light on the role of viruses in pneumonia, and current research indicates that the incidence of viral pneumonia is severely underestimated.
optimize patient care
Without PCR, physicians have no clear reason to treat patients with obvious viral community-acquired pneumonia with antibiotics as well. By utilizing both the bacterial and viral molecular diagnostic physicians can understand the cause and pathogenesis of community-acquired pneumonia and other respiratory infections, and select the most targeted, effective approach possible to speed patient healing.